Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Wassil Nowicky

Wassil Nowicky

Ukrainian Anti-Cancer Institute Austria

Michael Retsky

Michael Retsky

Harvard TH Chan School of Public Health USA

Yoshiaki Omura

Yoshiaki Omura

New York Medical College USA

Diana Anderson

Diana Anderson

UK

Yoko Matsumoto

Yoko Matsumoto

Sojo University Japan

Stefan Gluck

Stefan Gluck

Celgene Corporation USA

Manuela Lacerda

Manuela Lacerda

IPATIMUP Portugal

Ratna Parikh

Ratna Parikh

Breach Candy Hospital India

oncologyresearch 2021

About the Conference

Conferenceseries Ltd welcomes everyone all over the world to participate in the “Global Summit on Oncology and Hematology” during April 05-06, 2021 Webinar.

Oncology 2021 coordinates towards tending to main issues as well as future strategies of Cancer. This will be the biggest and most encouraging universal gathering where the program incorporates Clinical Oncologists, Registered Nurses, Nurse specialists and the whole restorative group required in patient care, scientists, proficient, early profession people who wish to learn standards of tumour immunology and immunotherapy well as leaders will come to examine on different parts of challenges, risks and investment opportunities of Cancers. Global Cancer at Singapore will manage Cancer Prevention, Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies. Global Cancer  will also provide the three days of discussions on techniques and systems identified with administration and quality change of Cancer and in addition to investigate the new thoughts and ideas on worldwide scale and the themes incorporate lung malignancy, bosom disease, bone tumour, leukaemia, blood cancer, cervical tumour, colon-rectum disease, pediatric malignancy, surgical tumour, Prostate growth, thyroid malignancy.

ConferenceSeries llc LTD which contains 3000+ Global Events with more than 600+ Conferences, 1200+ Symposiums and 1200+Workshops on assorted Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is arranging meetings everywhere throughout the globe. Conferenceseries LLC has various Cancer Gatherings, Cancer meeting, worldwide growth gathering, European Oncology Conferences, Surgical oncology like skin tumour gathering, bosom malignancy meeting, liver malignancy gathering, Lung Cancer gatherings, and Oncology Conferences where learning exchange happens through civil arguments, round table discourses, notice introductions, workshops, symposia and presentations and which gets potential outcomes for treating the maladies with new time, innovation and research.

Who and Why??

ONCOLOGY RESEARCH 2021 Conference brings together the specialists from all the aspects to discuss about the future of Oncology and Cancer in today’s world to thrive and survive with a better health. Directors specialists, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies, Healthcare Institutions, Market Research and Consulting Firms, Pharmaceutical Companies and all other interested participants willing to enhance and update the knowledge may attend the conference.

 Cancer Science & Oncology:

 The branch of health care that determines the safety & efficacy of medications, devices, and diagnostics and also treatments intended for human use is termed  Clinical Research .These are used for the treatment , prevention, diagnosis and relieving symptoms of the diseases. Clinical research may differ from clinical practice. Clinical Practice uses established process , whereas in case of clinical research evidence is collected for establishing the new treatment using “biological marker” .i.e. Biomarker refers to the category of medical signs or say objective indications of the medical state which is observed from outside the patient – and is measured accurately.

Tracks

Track 1: Cancer Stem Cell

Cancer Stem Cell (CSC) hypothesizes the presence of a little populace of diseased cells with characteristic properties like protection from traditional radio-chemotherapy regiments and increased metastatic potential. Clinically, the forceful idea of CSCs has been appeared to connect with expanded tumour repeat, metastatic spread, and generally very low patient result over various malignant growth subtypes. Separation of CSC’s has been achieved through the use of cell surface markers by the useful contrasts among CSCs and remaining tumour cells have been portrayed through expansion, separation, and constraining weakening measures.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

 

Track 2: Oncology Research

Oncology is a part of the medication that bargains with the anticipation, conclusion, and treatment of Cancer disease. Survival has been enhanced because of three primary segments including enhanced counteractive action endeavours to diminish presentation to chance elements (e.g., tobacco smoking and liquor utilization) enhanced screening of a few tumours (taking into consideration prior finding), and upgrades in treatment.

Malignant growths are regularly overseen through discourse on multi-disciplinary disease gatherings where radiation oncologists, pathologists, radiologists, and organ particular oncologists meet to locate the most ideal administration for an individual patient considering the physical, social, mental, and money related status of the patient. It is vital for oncologists to keep refreshed as for the most recent headways in oncology, as changes in administration of malignancy are very normal.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

 

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

 

 Track 3: Oncology Research Categories

Cancer Oncology examines are being led remembering different classes or criteria like area, influenced organ, sort of Cancer disease, kind of consideration or drug, condition or encompassing.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

 

Track 4: Stem cells

Stem Cells are Biological cells that can separate into different sorts of cells and can divide to deliver same kind of cells in huge numbers. They are found in multicellular life forms. In mammals, there are two wide kinds of stem cells: embryonic stem cells, which are isolated from the internal cell mass of blastocysts, and adult stem cells, which are found in different tissues.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

 

Track 5: Bio-markers of Cancer Stem Cells

Liver cancer is the fifth most analysed and the second most ceaseless reason for cancer death in men around the world. Amongst liver cancers, hepatocellular carcinoma (HCC) represents the major histological subtype and it is one of the most common malignant human tumours. Research into the molecular biology of hepato-carcinogenesis has identified several biomarkers, which could provide additional information in order to better understand the biology of HCC. A large number of biomarkers have been shown to have probable predictive significance and a wide variety of molecular markers have been proven to be excellent diagnostic tools for HCC however it is hard to represent HCC with a single biomarker. Therefore, marks of a mix of biomarkers might be more important for the finding, arranging and visualization of HCC. Specifically, a correlation of HCC-CSCs phenotype to specific hepatic cancer subtypes and to specific clinical and pathological features has not yet been reported in human liver tumours.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 6: Immunology

Immunology is a part of science that covers the study of immune systems in all living beings. Immunology outlines, measures, and contextualizes the physiological working of the immune system in conditions of both wellbeing and sicknesses; breakdowns of the immune system in immunological disorders , example : autoimmune diseases,, hypersensitivities  immune deficiency, and rejection of transplants: the physical, compound and physiological attributes of the segments of the  immune system in vitro, in situ, and in vivo. Immunology has applications in various orders of medication, especially in the fields of organ transplantation, oncology, rheumatology, virology, bacteriology, parasitology, psychiatry, and dermatology.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 7: Cancer Stem Cell Treatments

Cancer treatments against tumour, chemo-and radiotherapy, have various restrictions that prompt treatment disappointment and disease repeat. These cells are associated with tumour formation, support, metastasis and repeat. Consequently, with the end goal to create productive medicines that can prompt a dependable clinical reaction forestalling tumour backslide it is vital to create drugs that can particularly target and dispose of CSCs. On-going distinguishing proof of surface markers and comprehension of atomic element is related with CSC phenotype, assisted with the plan of viable medicines

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

 

Track 8: Types of Cancer

Cancer types include Carcinoma, Sarcoma, tumours got from epithelial cells. This gathering incorporates a large number of the most widely recognized malignancies and incorporate almost each one of those in the bosom, prostate, lung, pancreas and colon.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 9: Nanotechnology in Cancer

Cancer nanotechnology is a part of nanotechnology which deals with various techniques, equipment’s also known as Nano-materials to the analysis and treatment of cancer. It is the branch of nanotechnology that uses Nano-science and Nano vectors to cure or stop cancer cells and their growth

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

 

 

Track 10: Cancer Stages

Organizing can be "clinical" or "neurotic." Clinical organizing is based on the after effects of the tests done prior to the medical procedure for example:  physical examinations and imaging filters. Neurotic organizing based on what is found through the medical procedure. Clinical stage is regularly demonstrated by a lowercase "c" before the TNM grouping. The obsessive stage is demonstrated by a lowercase "p."

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 11: Cancer Causes

There can be more than one reason for cancer cells formation and growth. Various powers can cause quality changes, for example, smoking, radiation, infections, Cancer causing synthetic compounds (cancer-causing agents), heftiness, hormones, endless aggravation and an absence of activity.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

 

Track 12: Cancer Treatment

The causes for cancer may differ from genetic to the lifestyle of an individual. Cancer can spread from one region of the body to another and can also lead to death, there are some ways to treat or to reduce the spread of it.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 13: Cancer prevention

Cancer Prevention contains steps that are taken to bring down the danger of getting the Cancer disease. This can incorporate keeping up a solid way of life, to know disease causing substances, and taking prescriptions or immunizations that can keep cancer from formation.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

 

 

Track 14: Clinical research and trials in stem cells and cancer

Clinical preliminaries are broadly observed for real advances in Cancer treatment because of developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells attack solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia has restorative impact in which transplanted invulnerable cells attack leftover leukaemia or other tumour cells

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 15: Bioinformatics and Systems Biology

Bioinformatics and System Biology utilize PC techniques to investigate the natural information. As opposed to the past attention on single qualities or proteins, frameworks science is a field of research which focuses on understanding whole natural frameworks, for example: protein buildings, metabolic pathways, or quality administrative systems.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 16: 3D Bio printing & Bio fabrication

Bio fabrication is alluded to the generation of fake tissues or organs to address wellbeing challenges in medication. It frequently utilizes the rule of 3D Bio printing to shape cells, gels and strands into an organ.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 17: Gene therapy

Gene Therapy is an exploratory strategy that utilizes qualities to treat or anticipate ailment. Later on, this strategy may enable specialists to treat confusion by embedding a quality into a patient's cells as opposed to utilizing medications or medical procedure. In spite of the fact that gene therapy is a promising treatment alternative for various ailments (counting acquired disarranges, a few sorts of malignancy, and certain viral contaminations), the system stays hazardous is still under examination to ensure that it will be protected and successful. Gene Therapy is as of now being tried just for maladies that have no different fixes

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 18: Stem Cell Biology and advances

Most of the structural microorganisms have the astonishing potential to form into a wide range of cell types, basically unlimited to renew different cells until the individual is alive, offering any expectation of relieving Alzheimer's disease , treating kidney, liver and lung diseases . Until today, researchers principally worked with two types of undistinguishable organisms from creatures and people that are embryonic foundational microorganisms and non-embryonic "physical" or "grown-up" undeveloped cells. Late leap forward make it conceivable to change over or "reconstruct" specific grown-up cells to expect a stem cell with various improvements. The audit will quickly talk about the on-going developments here.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 19: Advances in Tissue Regeneration

Tissue Engineering is a logical field and depicted as understanding the benchmarks of tissue and its improvement by handy exchange of insufficient tissue for clinical use. Tissue building deals about the investigation of mixing of cells, structuring, materials and methodologies, biochemical segments to upgrade characteristic tissues. It includes the utilization of Scaffolds to shape practical tissues and organs, which can be embedded, again into the benefactor, have with the utilization of many building and materials techniques alongside some hemispherical elements. It is recognized with in excess of one branch which applies building information and life science ideas towards the advancement of natural substitutes which can enhance or re-establish all the qualities of an organ.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 20: Umbilical Cord Stem Cells

Moral and logical issues encompass both embryonic and fatal Cord Stem cells and frustrate their across the board usage. Interestingly, foundation microorganisms recuperated postnatal from the umbilical line, including the umbilical string platelets, amnion/placenta, umbilical rope vein, or umbilical string lattice cells, are a promptly accessible and modest wellspring of cells that are fit for framing a wide range of cell types (i.e., they are "multi-potent"). This survey will centre around the umbilical rope determined immature microorganisms and contrast those cells and grown-up bone marrow-inferred melancholy undifferentiated organisms.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 21: Stem Cell and Tissue Homeostasis

Tissue homeostasis depends upon the precise direction of substantial foundational microorganism movement. Substantial undeveloped cells need to react to tissue and therefore harm and multiply as per tissue requirements, while staying away from over-multiplication. The administrative systems engaged with these reactions are presently being separated in the intestinal epithelium of Philosophical, giving new understanding into procedures and components of undeveloped cell direction in obstruction epithelial.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 22: Stem Cell Aging

Maturing tissues encounter a dynamic decrease in homeostatic and regenerative limits, which has been credited to degenerative changes in tissue-particular foundation microorganisms, undifferentiated organism specialties and fundamental signals that manage undeveloped cell action. Understanding the sub-atomic pathways associated with this age-subordinate crumbling of immature microorganism capacity will be basic for growing new treatments for maladies of maturing that objective the particular reasons for age-related utilitarian decay. Here we investigate key sub-atomic pathways that are generally irritated as tissues and undifferentiated organisms age and savage.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 23: Stem Cell Therapy

Essential microorganisms are the body's rough materials cells from which each other cell with particular boundaries are created. New stem cells either end up being new undifferentiated cells with a more specific limit for instance: platelets, mind cells, heart muscle cells or bone cells. No other cell in the body has the featured ability to make new cell types.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 24: Recent advances in Stem Cell

All the immature microorganisms possess an amazing potential to form into various cell types, basically unbounded to renew different cells as long as the individual is alive, thus offering monstrous any desire for relieving Alzheimer's ailment, fixing harmed spinal lines, treating kidney, liver and lung sicknesses. Until today, researchers essentially worked with two sorts of undeveloped cells from creatures and people: embryonic undifferentiated cells and non-embryonic "substantial" micro-organisms. On-going achievement makes it conceivable to change over or "re-invent" specific grown-up cells to expect stem-like cells with various advancements. The survey will quickly talk about the on-going advances here.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 25: Epidermal Stem Cells

The skin continually re-establishes itself for the duration of grown-up life, and the hair follicle experiences an interminable cycle of development and degeneration.   Microorganisms (Stem cells) dwelling in the epidermis and hair follicle guarantee the support of grown-up skin homeostasis and hair recovery, however they likewise take part in the fixation of the epidermis after wounds.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 26: Stem Cell Renewal

In numerous tissues, mammalian maturing is linked with a decrease in the replicative and effective limit of physical immature microorganisms and other self-recharging compartments. Therefore understanding the premise of this decay is a noteworthy objective of maturing research. . Such methodologies incorporate accomplishments to shield undifferentiated organisms from age-advancing harm, to 'revive' foundation microorganisms using pharmacologic specialists that moderate maturing impelled modifications in flagging, and to replace lost undeveloped cells through regenerative drug approaches. Some progress has been made in every one of these fields in the course of the most recent year and a half incorporating advances in the generation of contributor particular supreme undifferentiated organisms through prompted diplomat, gains in our command of how tumour silencer flagging is controlled in self-restoring compartments to direct maturing, and further show of extracellular 'milieu' factors that bother undeveloped cell work with age.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 27: Ethics considerations in stem cell therapy

Stem Cell Research offers incredible guarantee for understanding fundamental elements of human advancement and separation, additionally the expectation for new medications for illnesses, for example, diabetes, spinal line damage, Parkinson's ailment, and myocardial localized necrosis. In any case, human Stem Cell inquires about additionally raises sharp moral and political contentions. The reconstructing of substantial cells to deliver instigated pluripotent undifferentiated organisms keeps away from the moral issues particular to embryonic microorganism examine. In any hSC look into, be that as it may, troublesome problems emerge with respect to delicate downstream research, agree to give materials for hSC explore, early clinical preliminaries of hSC treatments, and oversight of hSC inquire about. These moral and strategy issues should be talked about alongside logical difficulties to guarantee that undeveloped cell examine is done in a morally suitable way. This article gives a basic investigation of these issues and how they are tended to in current approaches

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 28: Advances in developmental biology and stem cells

Developmental biology is proposed as "the stem cell of biological disciplines." Genetics, cell science, oncology, immunology, transformative components, neurobiology, and frameworks science has its heritage in formative science. Formative science keeps on moving on, while holding its very own character. While its relative controls separate into sciences with a limited arrangement of standards, precedents, and systems, formative science stays incredible, pluripotent, and generally undifferentiated. In numerous orders, particularly in transformative science and oncology the developmental point of view is being reaffirmed as a critical research program.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 29: DNA Damage, Mutation and Cancer

A huge number of chemicals and several physical agents, such as UV light and γ-radiation, have been related with the etiology of human cancer. Causing of DNA damage brought by these agents is an essential first step in the process of carcinogenesis. Evolutionary processes gave rise to DNA repair tools that are capable in repairing damaged DNA; yet replication of damaged DNA may take place prior to repair, particularly when they are induced at a high frequency. Damaged DNA replication may cause gene mutations, that may give rise to altered proteins.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

Track 30: MicroRNAs and cancer

MicroRNAs are a type of small non-coding RNA molecule that performs a vital role in post-transcriptional gene regulation. Since miRNAs were first identified in 1993, a number of studies have demonstrated that they act as tumor suppressors or oncogenes in human cancer, including colorectal, lung, brain, breast and liver cancer, and leukemia. Studies have previously revealed that miRNA profiling is important for the diagnosis and prognosis of patients with cancer, while certain miRNAs possess the potential to be used as diagnostic and prognostic biomarkers or therapeutic targets in cancer. Studies review and examines the roles of miRNAs in prognosis, cancer diagnosis and treatment, discusses the probable therapeutic modality of misusing miRNAs.

EUROPEAN SOCIETIES

Association of European Cancer Leagues, EAU Section of Oncological Urology, European Academy of Cancer Sciences, European Association for Cancer Research, European Association for NeuroOncology, European Breast Cancer Coalition, European CanCer Organisation, European Group for Blood and Marrow Transplantation, European Musculo-Skeletal Oncology Society, European Network of Cancer Registries, European Neurofibromatosis Association

ASIAN SOCIETIES

Asia-Oceana Research Organization on Genital Infection and Neoplasia, Asia-Pacific Journal of Clinical Oncology, Asian Society for Neuro-Oncology, Asian Society of Gynecologic Oncology, Australasian Lung Cancer Trials Group, Cancer Therapeutics Research Group, Asian Fund for Cancer Research

AMERICAN SOCIETIES

American Society of Clinical Oncology, American Society of Hematology, American Society for Radiation Oncology, Association of Community Cancer Centers, Cancer Trials Update, NCI, National Cancer Institute, National Comprehensive Cancer Network, Oncology Nursing Society, Society for Radiation Oncology Administrators, Society of Gynecologic Oncology

 

Market Anyalsis

Market analysis:

Cancer is a disease characterized by the abandoned growth and spread of abnormal cells. If the growth of abnormal cells is not controlled, it can result in death. In Worldwide, one in seven deaths is due to cancer.  cancer causes more deaths than AIDS, tuberculosis, and malaria. According to income when countries are grouped, cancer is the second leading cause of death in high-income countries (following cardiovascular diseases) and the third leading cause of death in low- and middle-income countries (following cardiovascular diseases and infectious and parasitic diseases).

Cancer Diagnostics Market:

The global market size of cancer diagnostics is expected to reach $22.7 billion from $7.1 billion in 2020. Growing prevalence of oncologic cases, constant technological innovations in diagnostics, and increasing requirement for effective screening tests are some of the main factors prompting the demand for screening tools across the world.

 
 

Rising awareness and supportive government enterprises are some other factors that are anticipated to increase the growth of the sector during the forecast period. The global cancer diagnostics market is fragmented based on technology, application, and region.  Increase in aging population and cancer cases are likely to create huge opportunity for cancer diagnostics.

Cancer Diagnostic Market, By Technology

 On the basis of technology, the cancer diagnostics market is divided into instrument-based and platform-based. In 2015, the instrument-based segment is predicted to account for a major share of the cancer diagnostics market, by product.

1) Platform Based:

  • In situ Hybridization
  • Flow Cytometry
  • Next-generation Sequencing
  • Microarrays
  • Others

2) Instrument Based:

  • Biopsy
  • Mammography
  • PET
  • Ultrasound
  • MRI
  • CT

Cancer Diagnostic Market, By Application

Based on the application, the diagnostics market is fragmented into breast cancer, lung cancer, colorectal cancer, melanoma, Leukemia and others. Breast cancer application is expected to account for a major portion of the cancer diagnostics market.

Based on region, the cancer diagnostics market is classified into North America, Europe, Asia, and Rest of the World. Rest of the World includes Latin America, Pacific countries, and Middle East and Africa. North America is predicted as the largest share in the cancer diagnostics market, followed by Europe and Asia.Cancer Diagnostic Market, By Region

 

Past Conference Report

Cancer Science 2020

40th Euro Congress on Cancer Science & Therapy was organized on May 25-26, 2020 at Rome, Italy. Cancer Science 2020 Congress has received a generous response from all over the world. This has been organized with the aim of endorsing the development of new perceptions and ideas for investigating the high level of knowledge reached by scientific community on Cancer Science and Therapy.

 The conference was organized around the theme “Strengthening the future to fight against cancer”. The congress entrenched a firm relation of future strategies in the field of Cancer Science with the scientific community.

This congress brought together  the Leading physicians, surgeons, Clinicians, Professors, Care Specialists, Students and other professionals in which many issues in Oncology field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for networking.

The eminent personalities at the conference were:

Sang Youn Hwang, Dongnam Institute of Radiological & Medical Sciences, Korea
Zheng Wu, Capital University of Physical Education and Sports, China
Eleni Petsalaki, University of Crete, Greece

Conference series llc LTD takes its pleasure to thank all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and all who supported the conference in every aspect for the magnificent presence at the venue.

Conference Series llc LTD is overwhelmed to announce the commencement of its 2nd Global Summit on Oncology and Hematology on April 05-06, 2021 Online Event. Oncology 2021 will be organized around the theme “Cancer Free World - Possible or Not”. The conference is CME & CPD Accredited.

We would like to Inquire your cordial existence.

For More details:  Oncology Conference


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 05-06, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Archives in Cancer Research Journal of Cancer Science & Therapy Journal of Integrative Oncology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner